Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Global multi-host genomic epidemiology of Acinetobacter baumannii reveals transmission at one health interfaces.

Nature communications·2026

Same author

Acinetobacter baumannii's ecology- more than meets the eye.

Nature communications·2026

Same author

<i>Acinetobacter</i>-the bad, the ugly, but also the good!

mSphere·2026

Same author

Molecular epidemiology and population structure of <i>Providencia stuartii</i> obtained from humans and other sources.

Microbiology spectrum·2025

Same author

In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies.

Cureus·2025

Same author

Harnessing the Endogenous Type I-F CRISPR/Cas System for Efficient Genome Engineering and Gene Repression in <i>Pseudomonas chlororaphis</i> LX24.

ACS synthetic biology·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Published on: August 4, 2023

Acinetobacter junii: an emerging One Health pathogen.

Alejandro Aguilar-Vera¹, Elena Bello-López¹, Gabriel Iván Pantoja-Nuñez²

¹Programa de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, México.

|April 12, 2024

Summary

Acinetobacter junii, an understudied pathogen, has spread globally and is found in both humans and animals. Some strains carry crucial antibiotic resistance genes, highlighting a One Health concern.

Keywords:

Acinetobacter junii One Health antibiotic resistance emerging pathogens genomic epidemiology resistome

More Related Videos

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides

Published on: November 2, 2021

Related Experiment Videos

Last Updated: Jun 28, 2025

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Published on: August 4, 2023

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides

Published on: November 2, 2021

Area of Science:

Microbiology
Genomics
Epidemiology

Background:

Acinetobacter junii is an opportunistic pathogen in humans and animals, yet it remains understudied.
While Acinetobacter baumannii is well-known, other Acinetobacter species may also pose significant health risks.

Purpose of the Study:

To conduct the largest genomic epidemiological study of Acinetobacter junii to date.
To investigate the global spread and transmission dynamics of A. junii between human and non-human hosts.

Main Methods:

Genomic sequencing and phylogenetic analysis of A. junii isolates.
Comparative analysis of human and non-human isolates to assess genetic relatedness.

Main Results:

Acinetobacter junii has a global distribution.
Human and non-human isolates of A. junii are not always well-differentiated, suggesting inter-species transmission.
Clinically relevant antibiotic resistance genes were found in both human and non-human isolates, with some located on plasmids.

Conclusions:

Acinetobacter junii should be recognized as an emerging One Health issue.
Future research should include environmental and animal reservoirs in molecular epidemiology studies of A. junii.
The findings support considering A. junii as a pathogen relevant to both human and veterinary medicine.